Linrodostat

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameLinrodostat
Drug Alias NameONO-7701BMS-986205
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors
TargetsIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsOral Squamous Cell CarcinomaSolid tumoursLaryngeal Diseases +[15] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[36] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaIND
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol Myers Squibb SrlcompanyBristol-Myers Squibb (China) Investment Co LtdThomas Jefferson University +[6] 
Inactive CompaniesDana-Farber Cancer Institute
Active IndicationsOral Squamous Cell CarcinomaLaryngeal DiseasesUrinary Bladder Neoplasms +[10] 
Inactive IndicationsSolid tumoursLung NeoplasmsSkin Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A